|
Look, just because FDA has not acted on the threat since the release in 2020 of that manipulated NASEM report the agency commissioned, don’t be lulled into thinking that the threat has gone away. No. Remember that FDA is notoriously slow-moving. It will act when it acts. The threat persists.
Our job, then, is to continue to communicate this very real threat to patients and prescribers so that, when FDA introduces restrictions, we’ve marshalled thousands of cBHT supporters to help push back. (We also need their support in funding our campaign.)
That’s one purpose of the PBS piece. You can help spread the word. How?
- By airing the video in a loop in your waiting area of your pharmacy.
- By sharing the video with the prescribers you work with (and asking them to contribute).
- By showing the video in your exhibit booth at any prescriber- or patient-focused trade shows at which you exhibit.
We must build greater support for our campaign to save compounded hormone therapy.
Watch the video. Then share the video. And don’t forget to invest in the campaign.
This week’s news below…
| 
